Biomedical Technology
Graphene for healthcare applicationsÂ
As the demand for healthcare services continues to increase, so does the demand for novel healthcare solutions. These solutions should be more effective, cost less, prevent and cure disease, and should be equally effective throughout the world. Graphene is paving the way for novel diagnosis and treatments, thanks to its unique properties, such as high surface area, electron mobility, and functionalisation potential; all favourable for biomedical technologies.
For instance, the surface area of graphene makes an excellent platform for drug delivery and the conductivity makes for effective biosensors. The ability of graphene to be made into scaffolds whilst maintaining the inherent conductivity can be put to use in tissue engineering. New research has shown that graphene can be incorporated with a polymer to make very sensitive electromechanical sensors, and that it can be used to make improved deep brain implants.
The most advanced and promising areas in the biomedical field are currently those where graphene is used in a device configuration. For example, in Point-of-Care or In Vitro diagnostics, graphene can be used as a sensor and be duly functionalized to tune its sensing capabilities. Graphene-based neural interfaces have also demonstrated the possibility to not only detect wavelengths in the brain that cannot be detected with current metal-based technologies, but also to stimulate the tissue, opening up possibilities for new therapies.
​Cinzia Spinato, Business Developer for biomedical applications for the Graphene Flagship
Graphene Biomedical Products
From graphene-based retinal implants to robotic prosthetic hands controlled by wearable sensors made by cellulose and graphene composites. Graphene Flagship researchers are using graphene to expand the realm of possibility within the biomedical sector.
The latest on Biomedical Technology
BeDimensional and Rice University demonstrate destruction of PFAS “forever chemicals” using few-layer hBN
BeDimensional Presents the First Industrial Implementation of Graphene Heating Paint in Genoa
The event marks the operational debut of the technology, applied in a real-world context through a conductive solution capable of generating heat uniformly and efficiently, confirming BeDimensional’s pioneering role in the energy transition through advanced materials
Melexis and Graphenea Accelerate Graphene Biosensor Development
Graphenea Semiconductor, a leading graphene foundry company and partner in the Graphene Flagship's 2D Pilot Line project and Melexis, a global supplier of micro-electronic semiconductor solutions, announces a strategic collaboration to accelerate the development and evaluation of Melexis’ integrated GFET-on-CMOS platform for advanced biosensing.
Responsible use of GenAI in the Graphene Flagship
The Graphene Flagship has created a set of recommendations on the responsible use of GenAI in its projects.
MUNASET Publication: Emergence of graphene-based biosensors for depression treatment
Recent research on various biomarkers for major depressive disorder (MDD) provide an opportunity to develop biosensors that can overcome the challenges faced by conventional diagnostic tools, MUNASET researchers say.
BeDimensional redefines leather performance and comfort with B-LEAF, the innovative atom-thin additive
Leather meets advanced materials